Loading clinical trials...
Loading clinical trials...
This study will determine the maximum tolerated dose and the optimal associated 4 weekly dosing schedule of RO5045337, administered as monotherapy in patients with advanced solid tumors. A first cohor...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT07287098 · Breast Neoplasms
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT07169851 · Nausea, Vomiting, and more
NCT07628998 · Colorectal Neoplasms, Early Detection of Cancer
NCT07213609 · Neoplasms, Colorectal, Neoplasms
Aurora, Colorado
Boston, Massachusetts
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions